Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization. - Wikidata - wikimedia - TriplyDB

Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.

Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.

http://www.wikidata.org/entity/Q46773448

about

Bioactive Compounds and Their Neuroprotective Effects in Diabetic Complications Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease models Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress Impact of Plant-Derived Flavonoids on Neurodegenerative Diseases.Effects of Silymarin on Diabetes Mellitus Complications: A Review.Neuroprotective and anti-inflammatory effects of morin in a murine model of Parkinson's disease.Silymarin Ameliorates Diabetes-Induced Proangiogenic Response in Brain Endothelial Cells through a GSK-3β Inhibition-Induced Reduction of VEGF Release.Neuroprotective strategies to prevent and treat Parkinson's disease based on its pathophysiological mechanism.Polyphenols in Parkinson's Disease: A Systematic Review of In Vivo Studies.Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences.

P2860

Q26739955-6DF2FC7D-91C5-48E6-8563-50E823B7B8FA Q26775886-9A7148B6-759E-4C9F-BF94-A16050134DA5 Q36474039-F3E895BB-FA5E-4B99-8DC1-4B4C951C1487 Q36767908-7DEA5F0C-8435-4F8C-93F6-C74E6A292307 Q38764212-D129A82C-8D44-4BF7-BE76-725158E442A8 Q38998120-CA14DD9B-5A17-416B-9358-C3B827DCA67C Q46537044-472A5ACA-8DCE-4C8E-84B1-091737AA6EEF Q47133435-E7386A00-3D96-4385-9E7F-39731D754090 Q49797218-9BCD1DDF-EFAD-46B3-A641-868500C30CB5 Q55384361-6D7B9396-89FD-4296-867E-50ECCC2D3BA1 Q55405917-17C35A1E-A9ED-4C61-94E8-FC424E616125

P2860

Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.

http://www.wikidata.org/entity/Q46773448

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Silibinin prevents dopaminergi ...... a mitochondrial stabilization.

@en

Silibinin prevents dopaminergi ...... a mitochondrial stabilization.

@nl

type

label

Silibinin prevents dopaminergi ...... a mitochondrial stabilization.

@en

Silibinin prevents dopaminergi ...... a mitochondrial stabilization.

@nl

prefLabel

Silibinin prevents dopaminergi ...... a mitochondrial stabilization.

@en

Silibinin prevents dopaminergi ...... a mitochondrial stabilization.

@nl

P1433

Q46773448-5592A0D1-243E-4DD7-A6E8-724BF5DF9926

P1476

Q46773448-3E339981-3A29-4998-BB15-4C068B5502D3

P2093

Q46773448-1EC905B6-6E33-4C81-9CE1-30CB01462E4C

Q46773448-42065EA0-3401-4D5D-BC01-7D2AC26087B8

Q46773448-43EB477C-A2D5-461E-AF41-9B64858287DE

Q46773448-84A57873-1EE8-482D-9850-78FEDA977C6A

P2860

Q46773448-12E8272D-4C75-428D-835C-227DB3DA9882

Q46773448-14B2EF97-816D-436B-A05B-FA5146ED2572

Q46773448-2A7DB8DC-EFF0-4C23-963B-78A8F6AE1CCB

Q46773448-31C5AB29-9F7A-4C9D-BD84-1554FA208835

Q46773448-37E62701-87D6-45ED-B360-4028A6D9A159

Q46773448-39A9FF57-7EE9-4975-8109-B51A8C9683B9

Q46773448-43B82533-28CB-4B8D-A7DE-54748C47824D

Q46773448-49805B97-7EE4-4623-ABE2-DEC53C25D2D0

Q46773448-6F208062-029F-482B-ADEE-0A99D460C03C

Q46773448-71C33A8A-3834-4EDE-89E2-4674525FBDC6

P304

Q46773448-48ED3875-32AB-414E-88F9-58AC5FD7CAC9

P31

Q46773448-8F42C4B2-93B9-4B97-977A-85A4C9ED5A75

P356

Q46773448-0C7F2E3B-6932-43DD-BAB4-8056A875C714

P433

Q46773448-4C5D506B-35D5-41D5-B524-1FE25D4DDA22

P478

Q46773448-9CCA8E77-895A-4371-91A4-779E930532C1

P577

Q46773448-C10E9533-B8FA-4593-8349-BFCF47FA5C02

P698

Q46773448-559692A9-F618-4A9E-93A3-0173408638C2

P921

Q46773448-4894F1F4-01CB-40DE-BBE8-EBF4CBA91E53

Q46773448-CF93C4A3-F355-452B-93A3-1F99023D773D

P356

P1433

Journal of Neuroscience Research

P1476

Silibinin prevents dopaminergi ...... a mitochondrial stabilization.

@en

P2093

Hee Ra Park

http://www.w3.org/2001/XMLSchema#string

Hye Jeong Chun

http://www.w3.org/2001/XMLSchema#string

Jaewon Lee

http://www.w3.org/2001/XMLSchema#string

Yujeong Lee

http://www.w3.org/2001/XMLSchema#string

P2860

The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism.

Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells.

Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment.

Clinical approach to Parkinson's disease: features, diagnosis, and principles of management.

Expanding insights of mitochondrial dysfunction in Parkinson's disease.

Clavulanic acid inhibits MPP⁺-induced ROS generation and subsequent loss of dopaminergic cells.

Glial reactions in Parkinson's disease.

Parkinson's disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction.

Silymarin improved 6-OHDA-induced motor impairment in hemi-parkisonian rats: behavioral and molecular study

Genetic animal models of Parkinson's disease.

P304

755-765

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JNR.23544

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25677261

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease